GILD

144.74

1.87% -2.76

시간 외 거래: 144.91 0.17 +0.12%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$147.50

열려 있는:

$147.65

하루 거래량:

4.79M

Relative Volume:

0.77

시가총액:

$179.47B

수익:

$29.79B

순이익/손실:

$9.22B

주가수익비율:

19.69

EPS:

7.3494

순현금흐름:

$10.23B

1주 성능:

-4.10%

1개월 성능:

-3.26%

6개월 성능:

+3.60%

1년 성능:

+30.92%

1일 변동 폭

$144.00

$148.00

1주일 범위

$144.00

$152.74

52주 변동 폭

$109.66

$157.29

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1064)

산업

Drug Manufacturers - General (20)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,000

트위터

@GileadSciences

다음 수익 날짜

2026-10-29

최신 SEC 제출 서류

GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, MRK, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	144.74	179.47B	29.79B	9.22B	10.23B	7.3494
LLY Lilly Eli Co	1,142.85	1.02T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	256.03	623.34B	97.93B	21.04B	17.80B	8.6278
ABBV Abbvie Inc	262.82	459.33B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	144.30	354.80B	65.51B	8.93B	14.12B	3.5532
NVS Novartis Ag Adr	141.00	268.10B	54.66B	13.58B	16.05B	7.0171

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-10	개시	Jefferies	Buy
2026-02-20	개시	Barclays	Equal Weight
2026-02-11	재확인	Needham	Buy
2026-01-07	재개	UBS	Buy
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

Oct 01, 2026

Confluence Investment Management LLC Cuts Position in Gilead Sciences, Inc. $GILD - MarketBeat

Oct 01, 2026

More Upside Awaits for Gilead Sciences Stock. Stay Invested. - Barron's

Oct 01, 2026

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Oct 01, 2026

Gilead expands lenacapavir licenses: Gilead Sciences stock has 6.53 percent upside - AD HOC NEWS

Oct 01, 2026

Gilead Sciences stock pre-market at EUR 131.75: plus 0.54 percent - AD HOC NEWS

Oct 01, 2026

Sep 30, 2026

Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors - Yahoo Finance

Sep 30, 2026

Sep 29, 2026

Gilead Sciences, Inc. (GILD) stock price, news, quote and history - uk.finance.yahoo.com

Sep 29, 2026

Gilead Sciences (NASDAQ:GILD) Stock: Stronger HIV Sales Meet Weaker Reported Earnings - kalkine.ca

Sep 29, 2026

Sep 28, 2026

Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase? - Yahoo Finance

Sep 28, 2026

Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? - Yahoo Finance

Sep 28, 2026

Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? - Yahoo Finance

Sep 28, 2026

Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend? - Yahoo Finance

Sep 28, 2026

Gilead Sciences (GILD) Share Price, News, Stock Market Cap NASDAQ - TechGraph

Sep 28, 2026

Sep 27, 2026

CEUX:GISd Dividend: Does Gilead Sciences Inc Pay a Dividend? - GuruFocus

Sep 27, 2026

Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income? - Insider Monkey

Sep 27, 2026

Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? - Yahoo Finance

Sep 27, 2026

Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification? - Yahoo Finance

Sep 27, 2026

Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own? - Insider Monkey

Sep 27, 2026

Form 4 Gilead Sciences Inc For: 26 September By Investing.com - Investing.com Nigeria

Sep 27, 2026

Sep 26, 2026

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts - MarketBeat

Sep 26, 2026

Sep 25, 2026

Gilead Sciences stock closes at USD 149.69, down 1.11 percent at the close - AD HOC NEWS

Sep 25, 2026

UBS Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $175 - Moomoo

Sep 25, 2026

Gilead Sciences stock falls 1.11 percent despite revenue growth - AD HOC NEWS

Sep 25, 2026

Gilead Sciences, Inc. $GILD Stake Decreased by Envestnet Asset Management Inc. - MarketBeat

Sep 25, 2026

Gilead Sciences stock heads into the open after a 0.4 percent gain - AD HOC NEWS

Sep 25, 2026

Sep 24, 2026

Gilead Sciences Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Sep 24, 2026

Form DEF 14A Gilead Sciences Inc For: 24 September By Investing.com - Investing.com Canada

Sep 24, 2026

Gilead Sciences stock slips 0.85 percent ahead of the open - AD HOC NEWS

Sep 24, 2026

Sep 23, 2026

Gilead: HIV Growth Is Not Enough At The Current Price (NASDAQ:GILD) - Seeking Alpha

Sep 23, 2026

Gilead Sciences stock slips 1.30 percent at the close - AD HOC NEWS

Sep 23, 2026

Gilead Sciences, Inc. (GILD) latest stock news and headlines - Yahoo Finance Singapore

Sep 23, 2026

Gilead Sciences stock slips as earnings estimates shift - AD HOC NEWS

Sep 23, 2026

Can Gilead Sciences (NASDAQ:GILD) turn HIV leadership and oncology development into a stronger market story? - Kalkine Media

Sep 23, 2026

Gilead Sciences, Inc. (GILD) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026

Gilead Sciences stock slips 0.7 percent ahead of the open - AD HOC NEWS

Sep 23, 2026

Sep 22, 2026

Gilead Sciences Research Scholars Program in Solid Tumors – US 2026 - Oncodaily

Sep 22, 2026

Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH - The Motley Fool

Sep 22, 2026

Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know - Yahoo Finance

Sep 22, 2026

Gilead Sciences stock slips 0.7 percent at the close - AD HOC NEWS

Sep 22, 2026

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 22, 2026

Here's How Much $1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth Today - Benzinga

Sep 21, 2026

Gilead Sciences stock holds near 52-week high as HIV prevention deal and analyst optimism support va - AD HOC NEWS

Sep 21, 2026

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring Revenue Growth and Strategic Collaborations - DirectorsTalk Interviews

Sep 21, 2026

Erste Group Bank Estimates Gilead Sciences FY2027 Earnings - MarketBeat

Sep 21, 2026

Gilead Sciences stock heads into the open after a 0.52% dip - ad-hoc-news.de

Sep 21, 2026

Sep 20, 2026

Gilead Sciences stock gains as HIV drug access expands - AD HOC NEWS

Sep 20, 2026

Why Morgan Stanley likes Gilead’s HIV prevention play - thestreet.com

Sep 20, 2026

Why Is Gilead Sciences (GILD) Widening Lenacapavir Access Across 120 Countries? - Yahoo Finance

Sep 20, 2026